What Effect Will the Myriad Ruling Have on Biotech?

Much has been made of the importance of the lawsuit brought by the Association of Molecular Pathology and the ACLU against Myriad Genetics over the BRCA patents. The case was just heard by the Supreme Court and some feel a decision in favor of Myriad's patents would stifle research and enable companies to own our genes, whereas others voice concern that a decision against Myriad would undermine the biotech industry and stop the flow of innovative new medical technology. In fact, both positions seem a bit overblown. ...Read Full Post
Source: About.com Biotech Biomedical - Category: Biotechnology Source Type: news